- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Virax Biolabs Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| Mi | Virax Biolabs Group announces 1-for-25 share consolidation | 2 | Seeking Alpha | ||
| Mi | Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation | 170 | PR Newswire | LONDON, June 24, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that the board of directors of the Company... ► Artikel lesen | |
| VIRAX BIOLABS GROUP Aktie jetzt für 0€ handeln | |||||
| 12.06. | Virax Biolabs Group Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 26.05. | Virax reports early pilot data for long COVID blood test | 3 | Investing.com | ||
| 26.05. | Virax BioLabs Group Limited: Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes | 481 | PR Newswire | LONDON, May 26, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today reported positive early pilot performance data... ► Artikel lesen | |
| 22.05. | Virax Biolabs Group Ltd - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 19.05. | Why Is Virax Biolabs (VRAX) Stock Trending Overnight? | 2 | Benzinga.com | ||
| 15.05. | RedChip Companies, Inc.: Avalon Advanced Materials and Virax Biolabs Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 479 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / May 15, 2026 / RedChip Companies will air interviews with Avalon Advanced Materials Inc. (OTCQB:AVLNF)(TSX:AVL) and Virax Biolabs Group Limited (Nasdaq:VRAX) on the RedChip... ► Artikel lesen | |
| 11.05. | Virax Mulls Bringing UK Biotech Startup's Immune Profiling Platform to China, Chair Says | 1 | Yicai Global | ||
| 10.04. | Virax Biolabs Group Ltd - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 31.03. | Virax Biolabs-Tochter erhält ISO-Qualitätszertifizierungen | 2 | Investing.com Deutsch | ||
| 31.03. | Virax BioLabs Group Limited: Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation | 174 | PR Newswire | LONDON, March 31, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that Virax Biolabs (UK) Limited, its... ► Artikel lesen | |
| 30.01. | Virax Biolabs Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.01. | H.C. Wainwright senkt Kursziel für Virax Biolabs auf 1 US-Dollar | 2 | Investing.com Deutsch | ||
| 12.01. | Virax Biolabs stock price target lowered to $1 at H.C. Wainwright | 1 | Investing.com | ||
| 03.11.25 | Virax BioLabs Group Limited: Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes | 339 | PR Newswire | LONDON, Nov. 3, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection... ► Artikel lesen | |
| 26.08.25 | Virax BioLabs Group Limited: Virax Biolabs Partners with Emory University on ViraxImmune Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September | 342 | PR Newswire | LONDON, Aug. 26, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on immune... ► Artikel lesen | |
| 18.07.25 | Virax BioLabs Group Limited: Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency | 373 | PR Newswire | LONDON, July 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 82,45 | +3,13 % | Söllner: Nvidia, Intel; krasses Roboter-Ziel. Bitcoin böse, SpaceX, Palantir gut?! BioNTech, OHB | Heute stand der Hot Stock Report ganz im Zeichen der großen Frage, welche Aktien sich eher auf der "guten" und welche auf der "bösen" Seite der Börse einordnen lassen. Im Mittelpunkt stand dabei vor... ► Artikel lesen | |
| EVOTEC | 4,968 | +2,69 % | Blockbuster, Gold und Insiderverkäufe - Bayer AG, Evotec, North Arrow Minerals | Der erneute israelische Angriff im Libanon blockiert die eh schon unsicheren US-Iran-Gespräche massiv. Da Teheran die Hisbollah im Libanon unterstützt und den Frieden mit den USA an einen Frieden zwischen... ► Artikel lesen | |
| MODERNA | 60,32 | +2,08 % | Moderna: Ausbruch unter Druck? | Die Moderna-Aktie überschritt zuletzt einen wichtigen Widerstandsbereich und rückte damit aus charttechnischer Sicht in den Fokus. Doch der Ausbruch geriet schnell wieder unter Druck. Kann die Käuferseite... ► Artikel lesen | |
| VALNEVA | 2,271 | +0,22 % | VALNEVA SE: Valneva Announces Successful Outcome of its Annual General Meeting | Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that... ► Artikel lesen | |
| BIOGEN | 189,72 | -0,06 % | Biogen Inc.: Biogen to Highlight Breadth of Alzheimer's Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen | Diranersen presentation will feature Phase 2 CELIA data in early Alzheimer's disease, including clinical, biomarker and safety results for Biogen's investigational tau-targeting ASO, following topline... ► Artikel lesen | |
| ILLUMINA | 157,20 | +1,43 % | Bernstein SocGen resumes Illumina stock coverage with market perform rating | ||
| CRISPR THERAPEUTICS | 49,230 | +2,18 % | CRISPR Therapeutics AG: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results | ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. "The first quarter reflected... ► Artikel lesen | |
| VIVOSIM LABS | 1,050 | +1,94 % | VivoSim Labs, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | ||
| VIKING THERAPEUTICS | 34,650 | +3,74 % | Abnehm-Medikamente: Milliardenmarkt Adipositas: Der nächste Herausforderer für Novo und Lilly? | © Foto: JoNel Aleccia - picture alliance / ASSOCIATED PRESSViking Therapeutics startet die klinische Prüfung eines neuen Adipositas-Wirkstoffs. Damit wächst die Konkurrenz im Milliardenmarkt für Adipositas-Therapien.Viking... ► Artikel lesen | |
| VIVORYON THERAPEUTICS | 1,075 | +4,37 % | Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update | Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update
Compelling kidney function data and meta-analysis from two Phase 2 studies with varoglutamstat presented... ► Artikel lesen | |
| SAREPTA THERAPEUTICS | 14,940 | +0,81 % | Biotech-Player: Zelltherapie als Comeback-Story im Milliardenmarkt. Neue Ideen nach Corona von BioNTech, Qiagen und Biotech AG | ||
| VAXART | 0,380 | 0,00 % | Vaxart, Inc. - 8-K, Current Report | ||
| ATAIBECKLEY | 4,680 | +1,30 % | AtaiBeckley to join Russell 2000, 3000 indexes | ||
| ASEP MEDICAL | 0,100 | -100,00 % | CSE Bulletin: Suspensions - VSBLTY Groupe Technologies Corp., NuRAN Wireless Inc., GOAT Industries Ltd., BYT Holdings Ltd., ASEP Medical Holdings Inc., BioVaxys Technology Corp. | Le 6 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading... ► Artikel lesen | |
| XOMA ROYALTY | 37,400 | +0,54 % | XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date | EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) ("XOMA" or the "Company") today announced that its Board of Directors has authorized the following cash... ► Artikel lesen |
Das Unternehmen VIRAX BIOLABS GROUP LIMITED kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,140 (+4,50 %) liegt der Kurs bei 3,250 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIRAX BIOLABS GROUP LIMITED finden Sie auf Wallstreet Online.